Arbutus to present at jmp securities life sciences conference

Warminster, pa., may 09, 2023 (globe newswire) -- arbutus biopharma corporation (nasdaq: abus) (“arbutus” or the “company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the company will participate in a fireside chat at the jmp securities life sciences conference taking place in new york on tuesday, may 16, 2023 at 9:00 am et.
ABUS Ratings Summary
ABUS Quant Ranking